Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegasys + Copegus in HIV/HCV co-infected patients
NCT00296972Phase 3Terminated
- Sponsor
- University Health Network
- Start
- Jul 2005
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of peginterferon alfa-2a in hepatitis C (HCV), sponsored by University Health Network. Started Jul 2005; status: terminated.
02
Drugs
peginterferon alfa-2a
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00296972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00296972.